T‐cell engagers in small cell lung cancer
The management of small cell lung cancer (SCLC) has been transformed by the advent of effective T‐cell engagers (TCEs), which circumvent the traditionally immunosuppressive tumor microenvironment by directly facilitating T‐cell–mediated cell lysis. Delta‐like ligand 3 (DLL3) has emerged as the predominant target for TC...